Cutaneous effects of thiotepa in pediatric patients receiving high-dose chemotherapy with autologous stem cell transplantation

Journal of the American Academy of Dermatology

Volumn 58, Issue 4, 2008, Pages 575-578

  Rosman, Ilana S ^a   Lloyd, Brendan M ^a   Hayashi, Robert J ^a   Bayliss, Susan J ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CYCLOPHOSPHAMIDE; ETOPOSIDE; HYDROXYZINE; NALBUPHINE; THIOTEPA;

ADOLESCENT; ADRENAL CORTEX CARCINOMA; ADULT; ARTICLE; ASTROCYTOMA; BONE MARROW SUPPRESSION; CLINICAL ARTICLE; COMBINATION CHEMOTHERAPY; DESQUAMATION; DRUG EFFECT; DRUG MEGADOSE; ERYTHEMA; FEMALE; FOLLOW UP; HUMAN; HYPERPIGMENTATION; MALE; NEPHROBLASTOMA; NEUROBLASTOMA; NEUROECTODERM TUMOR; OSTEOSARCOMA; PRESCHOOL CHILD; PRIORITY JOURNAL; PRURITUS; RHABDOMYOSARCOMA; SCHOOL CHILD; SKIN MANIFESTATION; STEM CELL TRANSPLANTATION;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD, PRESCHOOL; CYCLOPHOSPHAMIDE; ERYTHEMA; ETOPOSIDE; HUMANS; INFANT; NEOPLASMS; PIGMENTATION DISORDERS; RETROSPECTIVE STUDIES; SKIN; SKIN DISEASES; STEM CELL TRANSPLANTATION; THIOTEPA;

EID: 40649107125     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2007.12.037     Document Type: Article

References (16)

1. Koppel R.A., and Boh E.E. Cutaneous reactions to chemotherapeutic agents. Am J Med Sci 321 (2001) 327-335
2. Singal R., Tunnessen Jr. W.W., Wiley J.M., and Hood A.F. Discrete pigmentation after chemotherapy. Pediatr Dermatol 8 (1991) 231-235
3. Schey S.A., Cooper J., and Summerhayes M. The "hand foot syndrome" occurring with chronic administration of etoposide. Eur J Haematol 48 (1992) 118-119
4. Hendrix J.D., and Greer K.E. Cutaneous hyperpigmentation caused by systemic drugs. Int J Dermatol 31 (1992) 458-466
5. Susser W.S., Whitaker-Worth D.L., and Grant-Kels J.M. Mucocutaneous reactions to chemotherapy. J Am Acad Dermatol 40 (1999) 367-398
6. Horn T.D., Beveridge R.A., Egorin M.J., Abeloff M.D., and Hood A.F. Observations and proposed mechanism of N,N′,N″-triethylenethiophosphoramide (thiotepa)-induced hyperpigmentation. Arch Dermatol 125 (1989) 524-527
7. Saarinen U.M., Hovi L., Makipernaa A., and Riikonen P. High-dose thiotepa with autologous bone marrow rescue in pediatric solid tumors. Bone Marrow Transplant 8 (1991) 369-376
8. Lucidarme N., Valteau-Couanet D., Oberlin O., Couanet D., Kalifa C., Beaujean F., et al. Phase II study of high-dose thiotepa and hematopoietic stem cell transplantation in children with solid tumors. Bone Marrow Transplant 22 (1998) 535-540
9. Antman K., Eder J.P., Elias A., Ayash L., Shea T.C., Weissman L., et al. High-dose thiotepa alone and in combination regimens with bone marrow support. Semin Oncol 17 Suppl (1990) 33-38
10. Finlay J.L., Goldman S., Wong M.C., Cairo M., Garvin J., August C., et al. Pilot study of high-dose thiotepa and etoposide with autologous bone marrow rescue in children and young adults with recurrent CNS tumors. J Clin Oncol 14 (1996) 2495-2503
11. Przepiorka D., Dimopoulos M., Smith T., Ippoliti C., Diener K., Luna M., et al. Thiotepa, busulfan, and cyclophosphamide as a preparative regimen for marrow transplantation: risk factors for early regimen-related toxicity. Ann Hematol 68 (1994) 183-188
12. Finlay J.L., August C., Packer R., Zimmerman R., Sutton L., Freid A., et al. High-dose multi-agent chemotherapy followed by bone marrow 'rescue' for malignant astrocytomas of childhood and adolescence. J Neurooncol 9 (1990) 239-248
13. Dunkel I.J., and Finlay J.L. High-dose chemotherapy with autologous stem cell rescue for patients with medulloblastoma. J Neurooncol 29 (1996) 69-74
14. Wolff S.N., Herzig R.H., Fay J.W., LeMaistre C.F., Brown R.A., Frei-Lahr D., et al. High-dose N,N′,N″-triethylenethiophosphoramide (thiotepa) with autologous bone marrow transplantation: phase I studies. Semin Oncol 17 Suppl (1990) 2-6
15. Greenspan E.M., Jaffrey I., and Bruckner H. Thiotepa, cutaneous reactions, and efficacy. JAMA 21 (1977) 2288
16. Horn T.D. Antineoplastic chemotherapy, sweat, and the skin. Arch Dermatol 133 (1997) 905-906